SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-10-065437
Filing Date
2010-12-08
Accepted
2010-12-08 17:16:24
Documents
10
Period of Report
2010-12-02
Filing Date Changed
2010-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v204976_8k.htm 8-K 45026
2 v204976_ex99-1.htm EX-99.1 329573
3 v204976_ex99-2.htm EX-99.2 146286
4 v204976_ex99-3.htm EX-99.3 62201
5 v204976_ex99-4.htm EX-99.4 80932
6 v204976_ex99-5.htm EX-99.5 130075
7 v204976_ex99-6.htm EX-99.6 87772
8 v204976_ex99-7.htm EX-99.7 86610
9 v204976_ex99-8.htm EX-99.8 86337
10 v204976_ex99-9.htm EX-99.9 31221
  Complete submission text file 0001144204-10-065437.txt   1087730
Mailing Address NO. 25 CHENGDE STREET DAWAI DISTRICT HARIN, HEILONGJIANG PROVINCE F4 150020
Business Address NO. 25 CHENGDE STREET DAWAI DISTRICT HARIN, HEILONGJIANG PROVINCE F4 150020 86 0451 88355530
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. (Filer) CIK: 0001484042 (see all company filings)

IRS No.: 262816569 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-165684 | Film No.: 101240530
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1